HB 3717: Relating to the establishment of a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the administration's approval as a medication for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy.

2025 session. Author: Cody Harris (R), Jeff Leach (R), Dade Phelan (R), Angelia Orr (R), Gary VanDeaver (R). Status: Died when the session ended.